0.907
0.01 (0.78%)
| Penutupan Terdahulu | 0.900 |
| Jumlah Dagangan | 21,967 |
| Harga / Buku (P/B) | 0.970 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -20.70 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 223.01% |
| Nisbah Semasa (MRQ) | 0.880 |
| Aliran Tunai Operasi (OCF TTM) | -15.83 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -9.03 M |
| Pulangan Atas Aset (ROA TTM) | -107.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -397.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Imunon, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | 4.0 |
| Volatiliti Harga | 2.2 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -4.9 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.53 |
|
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.19% |
| % Dimiliki oleh Institusi | 1.15% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Riverview Capital Advisers, Llc | 30 Jun 2026 | 34,364 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FALLER DOUGLAS VINCENT | 1.24 | - | 27,833 | 34,513 |
| LINDBORG STACY | 1.24 | - | 2,603 | 3,228 |
| TARDUGNO MICHAEL H | 1.24 | - | 6,821 | 8,458 |
| Jumlah Keseluruhan Kuantiti Bersih | 37,257 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 46,199 | |||
| Purata Pembelian Keseluruhan ($) | 1.24 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FALLER DOUGLAS VINCENT | Pegawai | 23 Oct 2026 | Diperolehi (+) | 27,833 | 1.24 | 34,513 |
| LINDBORG STACY | Pegawai | 23 Oct 2026 | Diperolehi (+) | 2,603 | 1.24 | 3,228 |
| TARDUGNO MICHAEL H | Pegawai | 23 Oct 2026 | Diperolehi (+) | 6,821 | 1.24 | 8,458 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |